Hims & Hers planning to sell compounded peptides
- Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call.
- The company’s CEO, Andrew Dudum, said in the earnings call that it was “currently developing a best-in-class peptides experience, including U.
- manufactured products, clinical-led guidance, and ongoing blood testing.
Unverified
- Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call.
- The company’s CEO, Andrew Dudum, said in the earnings call that it was “currently developing a best-in-class peptides experience, including U.
- manufactured products, clinical-led guidance, and ongoing blood testing.
Sources: The Hill